Try our Advanced Search for more refined results
Life Sciences - November, 2009
181 articles
- Calif. Court Cuts McKesson Penalty From $15M To $2M
- Abbott Settles TriCor Patent Spat With Teva
- High Court Mulls Statute Of Limitations In Investor Suits
- Invisalign Wins Right To Amend In Battle With Counsel
- Depomed Fingers Lupin In Diabetes Drug Patent Case
- NJ Law To Govern Punitives In Zometa, Aredia Cases
- Contract Claims V. Mayo Nixed In Alzheimer's IP Spat
- Punitive Damages Fight Revived In ObTape Case
- High Court Refuses Cordis, Boston Scientific Appeals
- Wyeth V. Levine Won't Affect Liability Win For Perrigo
- Generic-Drug Labels Must Provide Warnings: 8th Circ.
- Stryker To Buy Medical Device Reprocessor For $525M
- Wrongful Death Suit Over J&J's Remicade Closed
- Daiichi Sankyo Goes After Sandoz For Evoxac ANDA
- Consolidated Defendants Tossed From Colchicine Spat
- QLT Settles Visudyne Royalty Spat For $20M
- The Complications Of Successorship Decisions
- GSK Prevails In Sales Rep Overtime Suit
- Wal-Mart, CVS Win Bid To Toss Drug Overcharge Suit
- Ex-Taro Exec, Son Hit With Penalties In SEC Case
- Court Affirms St. Jude Win In Noncompete Dispute
- GSK Pulls H1N1 Vaccine Amid Reports Of Reactions
- Reconsidering Re-Examination — 10 Years Of Data
- Jury Tacks On $28M In Punitive Damages For Pfizer
- J&J Wants Consumer Class Tossed From AWP Suit
- Dow Corning Sues Merrill Over $166M In Failed ARS
- FDA Launches Safety Review Of Weight Loss Drug
- Merck Wins Bid To Toss Texas Medicaid Fraud Suit
- 2nd Bellwether Case Over Merck's Fosamax Nixed
- Zicam Maker Urges FDA To Reverse Anosmia Finding
- Medical Ed. Co. Says Ex-Worker Stole Source Codes
- $125M Deal Awaits OK In Bristol-Myers Class Action
- 1st Circ. Crushes Objection To $24M Zoladex Deal
- Pfizer Hit With $6.3M Prempro Verdict In Pa.
- P&G Recalls Nasal Spray Over Bacteria Risk
- Teva Will Appeal Loss In Vigamox Eyecare Patent Suit
- Exela Takes Alphagan Patent Ruling To Fed. Circ.
- FDA Enforcement Heating Up
- St. Jude Wins Motion To Recover Stolen Trade Secrets
- Novartis Wins Herpes Drug Patent Fight Against Teva
- Sheppard Mullin Lures IP Expert From Kelley Drye
- EU To Request Drug Patent Deal Details
- ARS Investor Seeks To Dump FINRA As Arbitrator
- OraSure To Pay $3M To Settle HIV Test Patent Suit
- Sughrue Mion Grabs Calif. Biotech Patent Attorney
- 9th Circ. Allows CTI Contract Dispute To Go Forward
- Congress Demands Health Insurers Explain Rate Hikes
- Plavix Label Revised To Include Prilosec Warning
- Bayer, GE, Covidien MRI Agents Carry Higher Risk: FDA
- House Dems Ask GAO To Look At Drug Prices
- FDA Warns Medtronic Over Heart Rhythm Unit
- Edwards Drags Medtronic To Court Over Valve Patent
- The Reluctance To Certify Mass Class Under CAFA
- PRE Loses Injunction Bid In Device Patent Suit
- US Seeks OK For $6M Ill. Contamination Settlement
- Norbrook, Boehringer End Dog Drug IP Brawl
- The Bifurcation Divide
- Teva Drops 2 Copaxone Claims Against Sandoz
- DeCode Files For Ch. 11 With Plan To Sell Assets
- CSI Recalls Sheath Introducers Amid Breakage Fears
- Seroquel Plaintiffs Rebuked Over Video Testimony Bid
- Streck Appeals Conflicting Patent Board Finding
- Importer Seeks Lower Duty On Vitamin Pills
- Takeda Appeals Win For Teva In Generic Prevacid Case
- Smith & Nephew Not Enjoined In Wound Therapy IP Suit
- Seller Of Fake Cancer Drugs Loses Bid For New Trial
- FDA Warns Abbott To Fix 'Adulterated' Devices
- McDermott Adds Darby & Darby Attys To NY IP Team
- Stanford Receiver Looks To Sell Sinking Investments
- Eli Lilly Escapes Suit Over Prozac Slaying, Suicide
- Dermatological Patent Spat Ends In Settlement
- AstraZeneca Fights Bid To Videotape Seroquel Expert
- High Court Will Not Review Bra-Tank Top Case
- Class Certified In Abbott Contact Lens Solution Suit
- Wyeth, Schwarz Off Hook In Generic Reglan Suit
- Arnold & Porter Snags Veteran Appellate Lawyer
- Bristol-Myers To Divest Mead Johnson Stake
- Class Cert. Bid Nixed In J&J Panacryl Sutures MDL
- J&J Appeals Loss In CIBA Contact Lens Patent Suit
- W.Va. Plaintiffs To Fight Baycol MDL Ruling In 8th Circ.
- 9th Circ. Revives Amgen Drug Rebates Dispute
- More Bodybuilding Products Recalled Over Steroids
- Fed Circ. Refuses To Nix Injunction On USPTO Rules
- Dey, Others Fork Over $4.3M To End Iowa AWP Suit
- 8th Circ. Upholds Tossing Of Baycol Expert Testimony
- Frommer Bumped From Merck, ProThera Patent Suit
- Cephalon, Barr Settle Fentora Patent Battles
- FDA Warns Public About Post-Surgery Infusions
- Generics Maker Says Drug-Safety Program Gets Abused
- Arthrex Hit With Patent, Trade Secrets Claims
- New USPTO Director Wastes No Time Making Mark
- FDA Issues Safety Warning About 5 Genzyme Drugs
- WL Gore, Synovis End Feud Over Staple Seal Patent
- Wage-And-Hour Issues In The Life Sciences Industry
- 7th Circ. To Review Medicare Contract Antitrust Spat
- Abbott Gains Pain-Relief Drug In $190M Deal
- Growing Safe Food Act Vows Aid To Small Farms
- Pfizer Looks To Shake PCB Pollution Claims
- Endo To Pay $23M To Settle Patent Suit Over Patch
- Class Action Alleges Plot To Price-Fix Plasma Therapies
- St. Jude Parries Insurer's Bid To Sidestep Coverage
- ARS Investor Fights To Keep Citigroup In Court
- Lilly To Pay Utah $24M Over Zyprexa Marketing
- BPA MDL Against Bottle Makers Survives Bid To Toss
- Teva Launches Generic Prevacid After Patent Win
- Different FDA Regs For Devices, Drugs Rule Preemption
- Knobbe Martens Nabs Ex-Ranbaxy VP Of Global IP
- Biovail Accuses Elan, Fournier Of Misleading USPTO
- Foley Lures Sheppard Mullin IP Chair To San Diego
- Merck Answers USPTO In Singulair Patent Re-Exam
- Conceptus Fails To Block Rival Contraceptive System
- Fraud Claims Cut From Actimmune Marketing MDL
- Threshold Settles Shareholder Action For $10M
- Bilski Argument Puts Spotlight On Business Methods
- Hospital Wage-And-Hours The Next Wave, Lawyers Say
- Celexa, Lexapro Deal Covers Civil Claims Only
- Sonova Snaps Up Advanced Bionics For $489M
- Takeda Sues Teva Over Sleeping Pill ANDA
- Plaintiffs' Demand For Docs Too Late In Seroquel MDL
- Ark. High Court Tosses Nexium Marketing Fraud Suit
- Allergan Hits Alcon With Combigan Patents
- House Passes Health Care Bill
- Ill. Cancer Hospital Hit With Whistleblower Suit
- Antitrust Concerns Revived As CVS Reveals FTC Probe
- Plaintiffs Drop Lipitor Class Action Against Pfizer
- Boston Scientific To Pay $296M To Settle Probe
- DOJ Probes Abbott's Sales, Marketing Of Depakote
- Mirapex Buyers Bid For Class Status In Antitrust Case
- Infosint Seeks $43M Damages In Citalopram Suit
- $1.7B Centocor Patent Award Against Abbott Stands
- Troutman Atty Tagged In $50M Omnicare Scheme
- Feds Search Rothstein's Firm In Missing Funds Probe
- P&G Sued Over Vicks With Vitamin C Products
- Ropes & Gray Atty Charged In Insider Trading Probe
- Insurers Shouldn't Fear New FTC Powers, Attys Say
- TPG Capital, Pension Plan To Buy IMS Health For $5B
- McKesson Wins Bid For Discovery Docs In AWP Fight
- Investors Slap Hansen Medical With Securities Action
- Centurion Recalls Kits With Faulty Tracheal Tubes
- Firms Say Industry Focuses Offer Edge In M&A Work
- Shire Settles With Apotex Over Epilepsy Patents
- After Jury Win, Patent Board Turns Tables On Streck
- Mutual Pharma Sanctioned In Sulindac Suit
- AtriCure To Pay $4M Over Ablation Device Marketing
- Pfizer Prempro Verdict Rumored To Be $75M
- ICL Sues Hawkins Over Failed Food Additive Deal
- Commerce Hails White House Pick For Export Post
- American Regent Expands Pain Injection Vial Recall
- Novartis Strikes $125M Deal For Chinese Vaccine Co.
- Online Vendor Recalls Supplements Over Steroids
- House Dems Amend Health Bill As Vote Approaches
- Differential Diagnosis — Trending Toward Exclusion
- Illumina Hits Affymetrix Over New Gene Tech Patent
- Kaiser Appeals Abbott MDL Antitrust Patent Case
- USPTO's Rescission Of Controversial Patent Rules
- Judge Pares Down Indirect Buyers' Wellbutrin Action
- Tender Offer Makes A Comeback
- Supreme Court Braces For Bilski Battle
- Omnicare, Teva Unit End Kickback Claims For $112M
- Cooley Lures Pillsbury Venture Capital Guru
- Sanofi, Bristol-Myers Try To Quash Apotex Subpoenas
- Rothstein Rosenfeldt Sues Partner Over Ponzi Scheme
- Breast Cancer Gene Patent Case Survives Bids To Toss
- Allergan Lashes Out At Eye Center In Patent Dispute
- Roche Drops NJ Boniva Suits After Teva Pulls ANDA
- FTC Extends Scrutiny Of MDS' $650M Sale To Danaher
- Neuralstem Loses Bid To Toss Stem Cell Patent Case
- Did SCOTUS Kill Product Design Trade Dress?
- Streck Wins Patent Suit Over Hematology Technology
- DOJ Targets Canadian Textile Co. Over Defective Zylon
- FDA Issues Warning Over Eli Lilly Diabetes Drug Byetta
- High Court Asks Solicitor General For Brief In Pfizer Suit
- 8th Circ. OKs $27M Damages Dismissal In Prempro Case
- FSI Hit With Fine Over Valve, Pump Export Violations
- Lilly To Appeal Invalidity Ruling For Sun In Gemzar Suit
- Supreme Court Declines Apotex Appeal Of Plavix Suit
- Conn. AG To Look Into Flu Vaccine Price-Gouging
- PerkinElmer Had Duty To Promote Printing Unit: 1st Circ.
- High Court Rebuffs Rx.com's Group Boycott Suit
- Purdue Hits Cipher With Patent Suit Over Ultram
- Solvay Wants Androgel Indirect Purchaser Cases Axed